-
USE OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS (GLP-1RAS) BEFORE BARIATRIC SURGERY IN THE US
Mar 18, 2026, 21:38 PM -
AI-ASSISTED GENERATION OF SYNTHETIC PATIENT-LEVEL DATA TO RECREATE WEIGHT-CHANGE OUTCOMES FROM THE STEP-4 SEMAGLUTIDE TRIAL
Mar 18, 2026, 21:38 PM -
COMPARISON OF ROBOTIC-ASSISTED ADRENALECTOMY USING THE DA VINCI SURGICAL SYSTEM WITH LAPAROSCOPIC AND OPEN APPROACHES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
QUANTIFYING EHR DISCONTINUITY IN PRAGMATIC TRIALS: INSIGHTS FROM THE NIDA CTN-074 PRIMARY CARE OPIOID USE DISORDERS TREATMENT (PROUD)STUDY
Mar 18, 2026, 21:38 PM -
DEVELOPING THE FIRST PRAGMATIC DOSE CONVERSION BETWEEN LONG-ACTING AND DAILY GROWTH HORMONE IN PREPUBERTAL CHILDREN WITH IDIOPATHIC SHORT STATURE: A JOINT MODELING METHOD USING REAL-WORLD DATA IN CHINA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ACUPUNCTURE TREATMENT COMPARED TO PLACEBO IN VETERANS WITH COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD)
Mar 18, 2026, 21:38 PM -
MODELING THE COST-EFFECTIVENESS OF RISK-STRATIFIED SCREENING FOR ESOPHAGEAL CANCER IN CHINA
Mar 18, 2026, 21:38 PM -
A REAL-WORLD RETROSPECTIVE COHORT STUDY CHARACTERIZING TREATMENT PATTERNS AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
THE NUMBER NEEDED TO TREAT WITH DUPILUMAB TO PREVENT MODERATE OR SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AND IMPROVE SYMPTOMS: BOREAS AND NOTUS POST HOC ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS OF PATIENTS TREATED WITH TALAZOPARIB + ENZALUTAMIDE FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN THE US COMMUNITY ONCOLOGY SETTING
Mar 18, 2026, 21:38 PM -
ADDRESSING MISSING DATA AND CONFOUNDING IN ACUTE KIDNEY INJURY RISK COMPARISON BETWEEN CORONARY ARTERY BYPASS GRAFTING AND PERCUTANEOUS CORONARY INTERVENTION USING MULTIPLE IMPUTATION AND PROPENSITY SCORE MATCHING
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN AMONG LUPUS NEPHRITIS PATIENTS WITH END-STAGE RENAL DISEASE: A REAL-WORLD CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLIER DETECTION AND THERAPEUTIC MANAGEMENT OF LEPTOMENINGEAL METASTASES USING CNSIDE: A COST-OF-CARE ANALYSIS
Mar 18, 2026, 21:38 PM -
SOURCES OF HOSPITAL ADMISSION COSTS IN HTA SUBMISSIONS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LEBRIKIZUMAB VERSUS NEMOLIZUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE US: A 10-YEAR ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
MEASURING MEANINGFUL ENGAGEMENT: A PATIENT ENGAGEMENT METRICS FRAMEWORK FOR PATIENT-GENERATED PRIMARY DATA QUALITY
Mar 18, 2026, 21:38 PM -
THE ILLUSION OF COMPLIANCE: WHY ECOA-ONLY MONITORING FALLS SHORT IN DETECTING AND ADDRESSING DATA GAPS
Mar 18, 2026, 21:38 PM -
EXPLANATION AND ELABORATION OF THE DEEM-Q CHECKLIST: GUIDANCE FOR ASSESSING THE METHODOLOGICAL QUALITY OF ECONOMIC EVALUATIONS OF MEDICAL DEVICES
Mar 18, 2026, 21:38 PM -
VALUE-BASED PURCHASING ARRANGEMENTS IN MEDICAID: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATABASES IN CHINA: REGIONAL LANDSCAPE, INTEGRATION CHALLENGES, AND METHODOLOGICAL PRACTICE
Mar 18, 2026, 21:38 PM
